Sign In to Follow Application
View All Documents & Correspondence

A Method Of Protein Hydrolysis And Uses Thereof

Abstract: The present disclosure relates to a method of hydrolysis of at least one proteinaceous substrate using at least one organic acid, resulting in a hydrolysate that has Angiotensin Converting Enzyme activity inhibitory potential.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 July 2015
Publication Number
02/2017
Publication Type
INA
Invention Field
BIO-CHEMISTRY
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Inventors

1. NAIR, Divya R
ITC Life Sciences & Technology Centre # 3 1st Main, Peenya Industrial Area, Phase 1 Bangalore 560 058, India
2. SINHA, Ranjana
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
3. KAUSHAL, Deepti
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
4. KALSI, Gurpreet
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
5. CHANDRASEKHARAN, Lakshmanan Chittur
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India

Specification

CLIAMS:1. A process for hydrolysis of at least one proteinaceous substrate to obtain a hydrolysate, said process comprising the steps of:
(a) obtaining at least one proteinaceous substrate;
(b) contacting said proteinaceous substrate with at least one organic compound to obtain a mixture and incubating said mixture at a temperature in the range of 22-30°C, at a pH in the range of 0.9-4, for a time period ranging from 0-0.5 hours to obtain a substrate;
(c) contacting said substrate from step (b) with at least one protease and incubating at a temperature in the range of 45-55°C, at a pH in the range of 5.5-7.5, for a time period in the range of 1-5 hours; and
(d) inactivating said protease from step (c) to obtain a hydrolysate,
wherein said hydrolysate inhibits angiotensin converting enzyme activity.

2. The process as claimed in claim 1, wherein said process optionally further comprises the step of centrifuging said hydrolysate obtained from step (d) at 10000-13000 rpm for 15-30 minutes to obtain a supernatant fraction.

3. The process as claimed in any of the claims 1-2, wherein said at least one proteinaceous substrate is selected from the group consisting of WPC-70, WPC-80, milk protein concentrate, milk protein isolate, and combinations thereof.

4. The process as claimed in any of the claims 1-2, wherein said at least one organic compound is selected from the group consisting of acetic acid, citric acid, and combinations thereof.

5. The process as claimed in any of the claims 1-2, wherein said at least one protease is selected from the group consisting of trypsin, pepsin, thermolysin, chymotrypsin, proteinase K, aminopeptidase, papain, actinase, renin, acid proteases, and combinations thereof.

6. Use of a process as claimed in any of the claims 1-5 to obtain a hydrolysate with angiotensin converting enzyme inhibitory activity.
,TagSPECI:As Attached

Documents

Application Documents

# Name Date
1 PD016442IN-SC SPEC FOR FILING.pdf 2015-07-08
2 PD016442IN-SC FORM 5.pdf 2015-07-08
3 PD016442IN-SC FORM 3.pdf 2015-07-08
4 PD016442IN-SC FIGURES FOR FILING.pdf 2015-07-08
5 3482-CHE-2015 POWER OF ATTORNEYT10-08-2015.pdf 2015-08-10
6 3482-CHE-2015 FORM-1 10-08-2015.pdf 2015-08-10
7 3482-CHE-2015 CORRESPONDENCE OTHERS 10-08-2015.pdf 2015-08-10
8 3482-CHE-2015-FORM 18 [12-06-2019(online)].pdf 2019-06-12
9 3482-CHE-2015-FER.pdf 2021-10-17

Search Strategy

1 patseersearchE_29-07-2021.pdf